Trimethoprim

甲氧苄啶

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameTrimethoprim
Drug Alias Nametrimetoprima三甲氧苄胺嘧啶三甲氧苄二氨嘧啶trimethoprimum磺胺增效剂 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsProstatic NeoplasmsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San DiegoMayne Pharma IncJiangsu Shenhua Pharmaceutical Co Ltd
Inactive CompaniesMonarch Pharmaceuticals LlcUniversity Of Pennsylvania
Active IndicationsProstatic NeoplasmsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01EA01
Related LinksWikipediaDrugBankKEGG